CCXI Stock Plummets: FDA Committee Split On Its Autoimmune Drug – Investor's Business Daily

Business News

  1. CCXI Stock Plummets: FDA Committee Split On Its Autoimmune Drug  Investor’s Business Daily
  2. SHAREHOLDER ALERT: Robbins LLP Announces That ChemoCentryx, Inc. (CCXI) is Being Sued for Misleading Shareholders  Business Wire
  3. Elizabeth Warren responds to Biden’s backing of COVID-19 vaccine patent waivers: ‘I’m delighted’  Yahoo Finance
  4. Why ChemoCentryx Stock Is Cratering Again Today  The Motley Fool
  5. FDA advisory committee votes 10-8 in favor of ChemoCentryx’s experimental drug; stock is down  MarketWatch
  6. View Full Coverage on Google News

Source: Business News

/by